Prognostic value of HPV18 DNA viral load in patients with early-stage neuroendocrine carcinoma of the uterine cervix

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3281-3285

  Siriaunkgul, Sumalee ^a   Utaipat, Utaiwan ^a   Suwiwat, Supaporn ^b   Settakorn, Jongkolnee ^a   Sukpan, Kornkanok ^a   Srisomboon, Jatupol ^a   Khunamornpong, Surapan ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

DNA viral load; HPV18; Human papillomavirus (HPV); Neuroendocrine carcinoma; Prognosis

Indexed keywords

EID: 84873596293     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3281     Document Type: Article

References (24)

1. Albores-Saavedra J, Gersell D, Gilks CB, et al (1997). Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med, 121, 34-9.
2. Cheung JL, Cheung TH, Ng CW, et al (2009). Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer. J Clin Microbiol, 47, 287-93.
3. Cohen MA, Basha SR, Reichenbach DK, Robertson E, Sewell DA (2008). Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients. Acta Otolaryngol, 128, 583-9.
4. Cooper K, Herrington CS, Stickland JE, Evans MF, McGee JO (1991). Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol, 44, 990-6.
5. Datta NR, Kumar P, Singh S, et al (2006). Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix?--a pilot study. Gynecol Oncol, 103, 100-5.
6. de Boer MA, Jordanova ES, Kenter GG, et al (2007). High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin Cancer Res, 13, 132-8.
7. Ersahin C, Szpaderska AM, Foreman K, Yong S (2005). Verucciform xanthoma of the penis not associated with human papillomavirus infection. Arch Pathol Lab Med, 129, e62-4.
8. Gnanamony M, Peedicayil A, Subhashini J, et al (2009). Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer. Int J Gynecol Cancer, 19, 1415-20.
9. Gravitt PE, Burk RD, Lorincz A, et al (2003). A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev, 12, 477-84.
10. Hsieh PP, Tung CL, Chan AB, et al (2007). EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma. Am J Clin Pathol, 128, 579-84.
11. Kang WD, Kim CH, Cho MK, et al (2011). HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy. Gynecol Oncol, 121, 546-50.
12. Kim JY, Park S, Nam BH, et al (2009). Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. J Clin Oncol, 27, 5088-93.
13. Kim YM, Park JY, Lee KM, et al (2008). Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma? J Gynecol Oncol, 19, 113-6.
14. Mellin H, Dahlgren L, Munck-Wikland E, et al (2002). Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer, 102, 152-8.
15. Ohkubo K, Kato Y, Ichikawa T, et al (2002). Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer, 94, 2663-8.
16. Patel S, Chiplunkar S (2009). Host immune responses to cervical cancer. Curr Opin Obstet Gynecol, 21, 54-9.
17. Saunier M, Monnier-Benoit S, Mauny F, et al (2008). Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol, 46, 3678-85.
18. Siriaunkgul S, Suwiwat S, Settakorn J, et al (2008). HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol, 108, 555-60.
19. Siriaunkgul S, Utaipat U, Settakorn J, et al (2011). HPV genotyping in neuroendocrine carcinoma of the uterine cervix in northern Thailand. Int J Gynecol Obstet, 115, 175-9.
20. Su JH, Wu A, Scotney E, et al (2010). Immunotherapy for cervical cancer: Research status and clinical potential. BioDrugs, 24, 109-29.
21. Wells M, Ostor AG, Crum CP, et al (2003). Epithelial tumors. Tumors of the uterine cervix. In 'Pathology and genetics of tumours of the breast and female genital organs. World Health Organization Classification of tumour', Eds Tavassoli FA, Devilee P. IARC Press, Lyon pp 262-79
22. Woodman CB, Collins SI, Young LS (2007). The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer, 7, 11-22.
23. Xi LF, Koutsky LA, Castle PE, et al (2009). Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. J Natl Cancer Inst, 101, 153-61.
24. Yoshida T, Sano T, Oyama T, Kanuma T, Fukuda T (2009). Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma. Virchows Arch, 455, 253-9.